Welcome To The BlockRx™ Token Sale

BlockRx

Blog

According to the United States Patent Office, the top 250 Universities spent $62 million on R&D and filed over 4,000 patents in 2011. These patents and the subsequent licenses generate revenue that can be reinvested in further research, improving infrastructure, and the student experience. In 2014, the World Intellectual Property Organization stated that 2.7M patents…

Read More

When people think of the term healthcare, they see it as a solid color puzzle. In reality, the term should be seen as a mosaic made up of Providers, Payers, Regulators, Suppliers, and Manufacturers. However one thinks of healthcare, it is important to keep in mind that there is no true interconnectivity between all of…

Read More

A case can be made that DNA (Deoxyribonucleic Acid) is the first example of ADLT™. It is decentralized, ubiquitous, requires verification, and has worked for millions of years. Its modern equivalent also shares many of the same characteristic features. Most people do not understand that what is unique about e-DNA (i.e ADLT™) is that it…

Read More

Whether you are a pharmacist, wholesaler, or manufacturer, you realize that the medication recall process requires drastic improvement. I have experienced this first hand as a pharmacist. There were several times when patients would come to the pharmacy and tell me they heard their medication was recalled; I hadn’t even received a fax notification about…

Read More

According to a 2014 Whitepaper by The ThomsenGroup, “.. non-adherence with prescription regimens is now a $300 billion problem in the US. The NCBI (National Center for Biotechnology Information )..noted that almost 50% of all prescribed medications are not taken according to directions…and nearly 25% are never initiated.” Non-adherence is problematic both from a National…

Read More

In the biopharma industry, inventory management is complicated by the fact that manufacturers do not have visibility into the post or pre-manufacturing supply chain and, as we provide lifesaving medications, there is a necessity to ensure that there is a sufficient supply to serve our patients. In some cases, there may also be a regulatory…

Read More

Recently, I spoke to a Pharma Company and asked them how much visibility they had into the manufacturing of APIs and other raw ingredients. The representative responded: “We don’t have any visibility into the API’s”. As with the rest of the supply chain, this lack of visibility has a significant impact on inventory levels and…

Read More

The use of Advanced Digital Ledger Technology™ (ADLT™), of which the Blockchain is an example, can have a tremendous impact on improving the flow of information across the entire supply chain. It empowers biopharmaceutical manufacturers as they now have direct access to supply chain and patient level data without using third party vendors.   But…

Read More

As the world of Blockchain enthusiast have spent a tremendous amount of time and effort focusing on how the Blockchain will revolutionize Fintech, many experts have realized the Blockchain may be a much better fit for the Pharmaceutical industry. Pharma has series of protocols, methodologies and processes surrounding the development, distribution and manufacturing of drugs. As drugs are…

Read More